Durgical
EN
Open the app

Antiglaucoma agents

Eye drops that lower intraocular pressure to protect the optic nerve: prostaglandin analogues, beta-blockers, alpha-2 agonists and others.

Updated

What they are

Drugs that lower intraocular pressure in open-angle glaucoma and ocular hypertension. Each group acts on a different step of aqueous humour: making less of it or draining more of it.

Mechanism of action

Prostaglandin analogues (latanoprost) increase uveoscleral outflow. Beta-blockers (timolol) and carbonic anhydrase inhibitors (dorzolamide) reduce aqueous production by the ciliary body. Alpha-2 agonists (brimonidine) do both. Cholinergic miotics (pilocarpine) open the trabecular meshwork by contracting the ciliary muscle.

Target: Aqueous humour production (ciliary body) and outflow (uveoscleral and trabecular)

Drugs in this class

Others in the class

  • Bimatoprost, travoprost
  • Betaxolol
  • Brinzolamide
  • Apraclonidine
  • Netarsudil

Test yourself

Think of the answer, then tap the question to see it.

Which antiglaucoma group increases uveoscleral outflow?

Prostaglandin analogues such as latanoprost.

Which two groups mainly reduce aqueous humour production?

Beta-blockers (timolol) and carbonic anhydrase inhibitors (dorzolamide).

Which antiglaucoma drop is dangerous in a patient with asthma?

Timolol, a non-selective beta-blocker.

Add to my cards (3)

More Pharmacology questions →

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - LATANOPROST solution/ drops (DailyMed (U.S. National Library of Medicine), 2024); DailyMed - TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION solution, gel forming / drops (DailyMed (U.S. National Library of Medicine), 2026); DailyMed - BRIMONIDINE TARTRATE- brimonidine tartrate solution/ drops (DailyMed (U.S. National Library of Medicine), 2025); DailyMed - DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION- dorzolamide hydrochloride solution/ drops (DailyMed (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.